Some people make it a New Year's resolution to improve their finances by investing in stocks. It's a laudable goal, and to ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

Financial writer recommends buying ARK Genomic Revolution ETF (ARKG) for potential growth in 2025. Explore more here.

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

Here are the best ones I've tested. Retail 2025-01-24T23:46:20Z Starbucks' new CEO made nearly $100 million in his first four months running the company — here's what's included in his pay ...

Riad Sattouf’s saga of his parents’ failed bicultural marriage, with its harsh depiction of life in rural Syria, has become a literary sensation. By Richard Fausset A popular TV host ...

A general view of the offices of Danish drugmaker Novo Nordisk in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Novo Nordisk on Friday announced early-stage trial results ...

The logo of social media platform X is seen on a mobile phone next to a reflection of Brazil's Supreme Court in this illustration taken August 30, 2024, in Brasilia, Brazil. REUTERS/Ueslei ...